Pubblicazioni

DNA-GEL, novel nanomaterial for biomedical applications and delivery of bioactive molecules

2020 - FRONTIERS IN PHARMACOLOGY

Lattuada, E.; Leo, M.; Caprara, D.; Salvatori, L.; Stoppacciaro, A.; Sciortino, F.; Filetici, P.

Lysine Acetyltransferase Inhibitors From Natural Sources

2020 - FRONTIERS IN PHARMACOLOGY

Fiorentino, F.; Mai, A.; Rotili, D.

How to Monitor Cardiac Complications of Immune Checkpoint Inhibitor Therapy

2020 - FRONTIERS IN PHARMACOLOGY

Spallarossa, Paolo; Sarocchi, Matteo; Tini, Giacomo; Arboscello, Eleonora; Toma, Matteo; Ameri, Pietro; Porto, Italo

How to Monitor Cardiac Complications of Immune Checkpoint Inhibitor Therapy

2020 - FRONTIERS IN PHARMACOLOGY

Spallarossa, P.; Sarocchi, M.; Tini, G.; Arboscello, E.; Toma, M.; Ameri, P.; Porto, I.

Selective estrogen receptor modulators in COVID-19. a possible therapeutic option

2020 - FRONTIERS IN PHARMACOLOGY

Calderone, A.; Menichetti, F.; Santini, F.; Colangelo, L.; Lucenteforte, E.; Calderone, V.

Altered waste disposal system in aging and Alzheimerâs disease: focus on astrocytic aquaporin-4

2020 - FRONTIERS IN PHARMACOLOGY

Valenza, Marta; Facchinetti, Roberta; Steardo, Luca; Scuderi, Caterina

Molecular mechanisms and new therapeutic targets in epithelial to mesenchymal transition (EMT) and fibrosis

2020 - FRONTIERS IN PHARMACOLOGY

STRIPPOLI, RAFFAELE; BATTISTELLI, CECILIA; Diederich, Marc; Keane, TJ; Sandoval, Pilar; VALENTE, Sergio

Editorial: Alzheimerâs disease: original mechanisms and translational impact

2020 - FRONTIERS IN PHARMACOLOGY

Mancuso, C.; Gaetani, S.

Modulation of pain sensitivity by chronic consumption of highly palatable food followed by abstinence: emerging role of fatty acid amide hydrolase

2020 - FRONTIERS IN PHARMACOLOGY

Cifani, C.; Avagliano, C.; Micioni Di Bonaventura, E.; Giusepponi, M. E.; De Caro, C.; Cristiano, C.; La Rana, G.; Botticelli, L.; Romano, A.; Calignano, A.; Gaetani, S.; Micioni Di Bonaventura, M. V.; Russo, R.

CDK9 as a valuable target in cancer: from natural compounds inhibitors to current treatment in pediatric soft tissue sarcomas

2020 - FRONTIERS IN PHARMACOLOGY

Cassandri, Matteo; Fioravanti, Rossella; Pomella, Silvia; Valente, Sergio; Rotili, Dante; Del Baldo, Giada; De Angelis, Biagio; Rota, Rossella; Mai, Antonello

Nanomaterials for Autophagy-Related miRNA-34a Delivery in Cancer Treatment

2020 - FRONTIERS IN PHARMACOLOGY

Sharma, Priyanka; Dando, Ilaria; Strippoli, Raffaele; Kumar, Suresh; Somoza, Alvaro; Cordani, Marco; Tafani, Marco

Cannabidiol treatment for refractory epilepsies in pediatrics

2020 - FRONTIERS IN PHARMACOLOGY

Raucci, U.; Pietrafusa, N.; Paolino, M. C.; Di Nardo, G.; Villa, M. P.; Pavone, P.; Terrin, G.; Specchio, N.; Striano, P.; Parisi, P.

Autophagy modulation in lymphocytes from COVID-19 patients. new therapeutic target in SARS-COV-2 infection

2020 - FRONTIERS IN PHARMACOLOGY

Vomero, M.; Barbati, C.; Colasanti, T.; Celia, A. I.; Speziali, M.; Ucci, F. M.; Ciancarella, C.; Conti, F.; Alessandri, C.

The Botanical Drug PBI-05204, a Supercritical CO2 Extract of Nerium Oleander, Inhibits Growth of Human Glioblastoma, Reduces Akt/mTOR Activities, and Modulates GSC Cell-Renewal Properties

2020 - FRONTIERS IN PHARMACOLOGY

Colapietro, A.; Yang, P.; Rossetti, A.; Mancini, A.; Vitale, F.; Martellucci, S.; Conway, T. L.; Chakraborty, S.; Marampon, F.; Mattei, V.; Gravina, G. L.; Biordi, A. L.; Wei, D.; Newman, R. A.; Festuccia, C.